These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33191223)

  • 1. Molecular Docking, Synthesis And Biological Evaluation Of Ergosteryl-Ferulate As A Hmg-Coa Reductase Inhibitor.
    Aziz S; Elfahmi -; Soemardji AA; Sukrasno -
    Pak J Pharm Sci; 2020 May; 33(3):997-1003. PubMed ID: 33191223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight into the mechanism of polyphenols on the activity of HMGR by molecular docking.
    Islam B; Sharma C; Adem A; Aburawi E; Ojha S
    Drug Des Devel Ther; 2015; 9():4943-51. PubMed ID: 26357462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioactivity guided fractionation and hypolipidemic property of a novel HMG-CoA reductase inhibitor from Ficus virens Ait.
    Iqbal D; Khan MS; Khan MS; Ahmad S; Hussain MS; Ali M
    Lipids Health Dis; 2015 Mar; 14():15. PubMed ID: 25884722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies.
    Dinesh N; Pallerla DS; Kaur PK; Kishore Babu N; Singh S
    Microb Pathog; 2014 Jan; 66():14-23. PubMed ID: 24239940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural mechanism for statin inhibition of HMG-CoA reductase.
    Istvan ES; Deisenhofer J
    Science; 2001 May; 292(5519):1160-4. PubMed ID: 11349148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding effect and design of a competitive inhibitory peptide for HMG-CoA reductase through modeling of an active peptide backbone.
    Pak VV; Koo M; Kim MJ; Yun L; Kwon DY
    Bioorg Med Chem; 2008 Feb; 16(3):1309-18. PubMed ID: 17977732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibitions of annonaceous acetogenins on class II 3-hydroxy-3-methylglutaryl coenzyme A reductase from Streptococcus pneumoniae.
    Feng L; Zhou L; Sun Y; Gui J; Wang X; Wu P; Wan J; Ren Y; Qiu S; Wei X; Li J
    Bioorg Med Chem; 2011 Jun; 19(11):3512-9. PubMed ID: 21550257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant 3-Hydroxy 3-Methyl Glutaryl-CoA Reductase from Candida glabrata (Rec-CgHMGR) Obtained by Heterologous Expression, as a Novel Therapeutic Target Model for Testing Synthetic Drugs.
    Andrade-Pavón D; Cuevas-Hernández RI; Trujillo-Ferrara JG; Hernández-Rodríguez C; Ibarra JA; Villa-Tanaca L
    Appl Biochem Biotechnol; 2017 Aug; 182(4):1478-1490. PubMed ID: 28138930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of virtual candidates for human HMG-CoA reductase inhibitors using pharmacophore modeling and molecular dynamics simulations.
    Son M; Baek A; Sakkiah S; Park C; John S; Lee KW
    PLoS One; 2013; 8(12):e83496. PubMed ID: 24386216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of degradation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase by sterol regulatory element binding protein cleavage-activating protein requires four phenylalanine residues in span 6 of HMG-CoA reductase transmembrane domain.
    Xu L; Simoni RD
    Arch Biochem Biophys; 2003 Jun; 414(2):232-43. PubMed ID: 12781775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IAF, QGF, and QDF Peptides Exhibit Cholesterol-Lowering Activity through a Statin-like HMG-CoA Reductase Regulation Mechanism: In Silico and In Vitro Approach.
    Silva M; Philadelpho B; Santos J; Souza V; Souza C; Santiago V; Silva J; Souza C; Azeredo F; Castilho M; Cilli E; Ferreira E
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-silico HMG-CoA reductase-inhibitory and in-vivo anti-lipidaemic/anticancer effects of carotenoids from Spondias mombin.
    Metibemu DS; Akinloye OA; Akamo AJ; Okoye JO; Omotuyi IO
    J Pharm Pharmacol; 2021 Sep; 73(10):1377-1386. PubMed ID: 34343336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of synthesis, biological assay, and QSAR studies of HMGR inhibitors.
    García I; Fall Y; Gómez G
    Curr Top Med Chem; 2012; 12(8):895-919. PubMed ID: 22352916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and highly potent hypolipidemic activity of alpha-asarone- and fibrate-based 2-acyl and 2-alkyl phenols as HMG-CoA reductase inhibitors.
    Mendieta A; Jiménez F; Garduño-Siciliano L; Mojica-Villegas A; Rosales-Acosta B; Villa-Tanaca L; Chamorro-Cevallos G; Medina-Franco JL; Meurice N; Gutiérrez RU; Montiel LE; Cruz Mdel C; Tamariz J
    Bioorg Med Chem; 2014 Nov; 22(21):5871-82. PubMed ID: 25311563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypolipidemic mechanism of oryzanol components- ferulic acid and phytosterols.
    Bhaskaragoud G; Rajath S; Mahendra VP; Kumar GS; Gopala Krishna AG; Kumar GS
    Biochem Biophys Res Commun; 2016 Jul; 476(2):82-9. PubMed ID: 27179780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in silico studies of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitory activity of the cowpea Gln-Asp-Phe peptide.
    Silva MBCE; Souza CADC; Philadelpho BO; Cunha MMND; Batista FPR; Silva JRD; Druzian JI; Castilho MS; Cilli EM; Ferreira ES
    Food Chem; 2018 Sep; 259():270-277. PubMed ID: 29680054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 3-hydroxy-3-methylglutaryl coenzyme-A reductases from fungi: a proposal as a therapeutic target and as a study model.
    Andrade-Pavón D; Sánchez-Sandoval E; Rosales-Acosta B; Ibarra JA; Tamariz J; Hernández-Rodríguez C; Villa-Tanaca L
    Rev Iberoam Micol; 2014; 31(1):81-5. PubMed ID: 24270073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore Modeling and Binding Affinity of Secondary Metabolites from
    Aulifa DL; Amirah SR; Rahayu D; Megantara S; Muchtaridi M
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38998937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis.
    Istvan ES; Palnitkar M; Buchanan SK; Deisenhofer J
    EMBO J; 2000 Mar; 19(5):819-30. PubMed ID: 10698924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based rational quest for potential novel inhibitors of human HMG-CoA reductase by combining CoMFA 3D QSAR modeling and virtual screening.
    Zhang QY; Wan J; Xu X; Yang GF; Ren YL; Liu JJ; Wang H; Guo Y
    J Comb Chem; 2007; 9(1):131-8. PubMed ID: 17206841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.